维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Hande KR"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Etoposide: four decades of development of a topoisomerase Ⅱ inhibitor显示文摘	Hande KR	1998	Eur J Cancer1998，34，10：	1
2	Etoposide:four decades of development of a topoisomerase II inhibitor 显示文摘	Hande KR	1998	Eur J Cancer1998，34，10：	1
3	New drugs on the horizen : matrix metalloprotemase inhibitor 显示文摘	Rothenberg ML Nelson AR Hande KR	1999	Stem Cells1999，17，4：	1
4	New drugs on the horizon:matrix metallo-proteinaseinhibitors显示文摘	Rothenberg ML Nelson AR Hande KR	1999	Stem cells1999，17，：	1
5	The importance Of drug scheduling in cancer chemotherapy : etoposide as an example 显示文摘	Hande KR	1996	The Oneologist1996，1，4：	1
6	Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor 显示文摘	Hande KR Collier M Paradiso L	2004	Clin Cancer Res2004，10，：	1
7	Etoposide: Four decades of development of a topoisomerase II inhibitor 显示文摘	Hande KR	1998	Eur J Cancer1998，34，：	1
8	New drugs on thehorizon: matriix mctallopmteinase inhibitors显示文摘	Rothenberg ML Nelson AR Hande KR	1999	Stem Cells1999，17，4：	1
9	Acute tumor lysis syndrome and alkali therapy显示文摘	Aviles A Hande KR Koduri PR	1995	Am J Med1995，98，：	1
10	Etoposide:four decades of development of a topoisomerase II inhibitor显示文摘	Hande KR		0，，10：	1
11	PhaseⅡstudy of paclitaxel,carboplatin,and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer显示文摘	Choyo H Devore RD Hande KR	1998	Proc Am Soc Clin Oncol1998，17，1：	1
12	New drugs on the horizon: matrix metalloproteinase inhibitors 显示文摘	Rothenberg ML Nelson AR Hande KR	1999	Stem Cells1999，17，：	1
13	Phase Ⅱ study of paclitaxel,carboplatin,and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer显示文摘	Choy H Devore RD Hande KR	1998	Pro Am Soc Clin Oncol1998，17，1：	1
14	Phase Ⅰ and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor显示文摘	HANDE KR COLLIER M PARADISO L	2004	Clin Cancer Res2004，10，3：	1
15	Acute tumor lysis syndrome in patiemts with high-grade mon-Hodgkin's lymphoma显示文摘	Hande KR Garrow GC	1993	Am J Med1993，94，2：	1
16	New drugs on the horizon:matrix metallo-proteinase inhibitors显示文摘	ROTHENBERG ML NELSON AR HANDE KR	1999	Stem cells1999，17，5：	1
17	Severe allopurinol toxicity:Description and guidelines for prevention in patients with renal insufficiency显示文摘	Hande KR Noone RM Stone WJ	1984	Am J Med1984，76，1：	1
18	Etoposide: four decades of development of a topoi- somerase II inhibitor 显示文摘	Hande KR	1998	Eur J Cancer1998，34，：	1
19	Clinical applications of anticancer drugs targeted to topoisomeraseⅡ显示文摘		1998	Biochim Biophys Acta1998，1400，13：	1
20	New drugs on thehorizon:matrix metalloproteinase inhibitors显示文摘	Rothenberg ML Nelson AR Hande KR	1999	Stem Cells1999，17，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示